Birth weight (BW) has been shown to be influenced by both fetal and maternal factors and in observational studies is reproducibly associated with future risk of adult metabolic diseases including type 2 diabetes (T2D) and cardiovascular disease 1 . These lifecourse associations have often been attributed to the impact of an adverse early life environment. Here, we performed a multi-ancestry genome-wide association study (GWAS) meta-analysis of BW in 153,781 individuals, identifying 60 loci where fetal genotype was associated with BW (P < 5 × 10 −8 ). Overall, approximately 15% of variance in BW was captured by assays of fetal genetic variation. Using genetic association alone, we found strong inverse genetic correlations between BW and systolic blood pressure (R g = −0.22, P = 5.5 × 10 ) and coronary artery disease (R g = −0.30, P = 6.5 × 10
, Sílvia Bonàs-Guarch 45 , David M. Hougaard 63, 64 , Friman Sánchez 45, 65 , David Torrents 45, 66 , Johannes Waage , Carolina Medina-Gomez 7, 8, 67 , Susan M. Ring 55, 56 , Gibran Hemani 55, 56 , George McMahon , Antje Körner 58, 73 , Thorkild I. A. Sørensen 55, 56, 74, 75 , Harri Niinikoski 76, 77 , Katja Pahkala 36, 78 , Olli T. Raitakari 36, 79 , Eleftheria Zeggini , Albert Hofman 7, 8 , Fernando Rivadeneira 7, 8, 67 LETTER RESEARCH ancestry or trans-ancestry meta-analyses (Extended Data Fig. 2a , Extended Data Table 1a and Supplementary Data; Methods). For lead single nucleotide polymorphisms (SNPs), we observed no heterogeneity in allelic effects between the three study components (Cochran's Q statistic P > 0.00083) (Supplementary Table 3 ). We found that 53 of these loci were novel in that the lead SNP mapped >2 Mb away from, and was independent (R 2 < 0.05 in the European (EUR) component of 1000G) of, the seven previously reported BW signals 5 , all of which were confirmed in this larger analysis (Supplementary Table  4 ). Approximate conditional analysis in the European ancestry data indicated that three of these novel loci (near ZBTB7B, HMGA1 and PTCH1) harboured multiple distinct association signals that attained genome-wide significance (P < 5 × 10 −8
) (Methods, Supplementary Table 5 and Extended Data Fig. 3) .
The lead variants for most signals mapped to non-coding sequences, and at only two loci, ADRB1 (rs7076938; R 2 = 0.99 with ADRB1 G389R) and NRIP1 (rs2229742, R448G), did the association data point to potential causal non-synonymous coding variants (Supplementary Table 6 and Methods). Lead SNPs for all but two loci (those mapping near YKT6-GCK and SUZ12P1-CRLF3) were common (minor allele frequency (MAF) ≥ 5%) with individually modest effects on BW (β = 0.020-0.053 standard deviations (s.d.) per allele, equivalent to 10-26 g). This was despite the much-improved coverage of lowfrequency variants in this study (compared to previous HapMap 2 imputed meta-analyses, ref. 5) reflecting imputation from larger, and more complete, reference panels (Extended Data Table 1b) . Indeed, all but five of the common variant association signals were tagged by variants (EUR R 2 > 0.6) in the HapMap 2 reference panel (Supplementary Tables 4, 5 ), indicating that most of the novel discoveries in the present study were driven by increased sample size 5 . Finemapping analysis yielded 14 regions in which fewer than ten variants contributed to the locus-specific credible sets that accounted for > 99% of the posterior probability of association (Methods and Supplementary Table 7) . The greatest refinement was at YKT6-GCK, where the credible set included only the low frequency variant rs138715366, which maps intronic to YKT6. These credible-set variants collectively showed enrichment for overlap with DNaseI hypersensitivity sites, particularly those generated, by ENCODE, from fetal (4.2-fold, 95% CI 1.8-10.7) and neonatal tissues (4.9-fold, 1.8-11.0) ( Supplementary  Fig. 1 , Supplementary Table 8 and Methods) .
In combination, the 62 distinct genome-wide significant signals at the 59 autosomal loci explained at least 2.0 ± 1.1% (standard error (s.e.)) of variance in BW (Supplementary Table 9 and Methods), which is similar in magnitude to that attributable to sex or maternal body mass index (BMI) 5 . However, the variance in BW captured collectively by all autosomal genotyped variants on the array was considerably larger, estimated at 15.1 ± 0.9% in the UK Biobank (Methods). These figures are consistent with a large number of genetic variants with smaller effects contributing to variation in BW.
Associations between fetal genotype and BW could result from indirect effects of the maternal genotype influencing BW via the intrauterine environment, given the correlation (R ≈ 0.5) between maternal and fetal genotype. However, two lines of evidence indicated that variation in the fetal genome was the predominant driver of BW associations. First, an analysis of the global contribution of maternal versus fetal genetic variation, using a maternal genomewide complex trait analysis (GCTA) model (ref. 6) (Methods) applied to 4,382 mother-child pairs, estimated that the child's genotype (σ C 2 = 0.24 ± 0.11) made a larger contribution to BW variance than either the mother's genotype (σ M 2 = 0.04 ± 0.10), or the covariance between the two (σ CM = 0.04 ± 0.08). Second, when we compared the point estimates of the BW-effect size dependent on maternal genotype at each of the 60 loci (as measured in up to 68,254 women 7 ) with those dependent on fetal genotype (using European ancestry data from 143,677 individuals in the present study), fetal variation had a greater impact than maternal variation at 93% of the loci (55 out of 60;
) (Supplementary Table 10 , Extended Data Figs 4, 5 and Methods). The power to further disentangle maternal and fetal contributions using analyses of fetal genotype which were conditional on maternal genotype was constrained by the limited sample size available (n = 12,909 mother-child pairs) (Supplementary Table 11) .
Collectively, these analyses provide evidence that the fetal genotype has a substantial impact on early growth, as measured by BW. We used these genetic associations to understand the causal relationships underlying observed associations between BW and disease, and to characterize the processes responsible.
To quantify the shared genetic contribution to BW and other health-related traits, we estimated their genetic correlations using linkage-disequilibrium score regression 8 (Methods). BW (in European ancestry samples) showed strong positive genetic correlations with anthropometric and obesity-related traits including birth length (R g = 0.81, P = 2.0 × 10 −44 ) and, in adults, height (R g = 0.41, P = 4.8 × 10 −52 ), waist circumference (R g = 0.18, P = 3.9 × 10 −10 ) and BMI (R g = 0.11, P = 7.3 × 10 −6 ). By contrast, BW showed inverse genetic correlations with indicators of adverse metabolic and cardiovascular health including coronary artery disease (CAD, R g = − 0.30, P = 6.5 × 10
), systolic blood pressure (SBP, R g = − 0.22, P = 5.5 × 10
−13
) and T2D (R g = − 0.27, P = 1.1 × 10 Table 12 ). The correlations between BW and adult cardiometabolic phenotypes are of similar magnitude, although directionally opposite, to the reported genetic correlations between adult BMI and those same cardiometabolic outcomes 8 . These findings support observational associations between a history of paternal T2D and lower BW (ref. 4) , and establish more generally that the observed life-course associations between early growth and adult disease, at least in part, reflect the impact of shared genetic variants that influence both sets of phenotypes.
In an effort to estimate the extent of genetic contribution to these life-course associations, we first focused on data from the UK Biobank (n = 57,715). For many of the traits for which data were available, genetic variation contributed substantially to the life-course relationship between BW and adult phenotypes, and in some cases appeared to be the major source of covariance between the traits. For example, we estimated that 85% (95% CI = 70-99%) of the negative covariance between BW and SBP was explained by shared genetic associations captured by directly genotyped SNPs (Supplementary Table 13 , Methods and Supplementary Fig. 2 ). For continuous cardiometabolic measures, including lipids and fasting glycaemia, for which measures are not currently available in the UK Biobank, we used data from the Northern Finland Birth Cohort (n = 5,009), and obtained similar results (Supplementary Table 13 ). However, these estimates were limited, not only by wide confidence intervals, but also by the assumption of a linear relationship between BW and each of the phenotypes and by the inability to explicitly model maternal genotypic effects. In other words, the inverse genetic correlations between BW and cardiometabolic traits may not exclusively reflect genetic effects mediated directly through the offspring, but also effects mediated by maternal genotype acting indirectly on the fetus via perturbation of the in utero environment. Nevertheless, these estimates indicate that a substantial proportion of the variance in cardiometabolic risk that correlates with BW can be attributed to the effects of common genetic variation.
To elucidate the biological pathways and processes underlying regulation of fetal growth, we first performed gene set enrichment analysis of our BW GWAS analysis using MAGENTA (Meta-Analysis Geneset Enrichment of variaNT Associations, ref. 9) approach (Methods). Twelve pathways reached study-wide significance (false discovery rate, FDR < 0.05), including pathways involved in metabolism (insulin signalling, glycogen biosynthesis and cholesterol biosynthesis), growth (IGF signalling and growth hormone pathway) and development (chromatin remodelling) (Extended Data Fig. 6a, b and Methods). The proteins within these modules were themselves enriched for diverse processes related to metabolism, growth and development (Extended Data Fig. 6a, b) .
We also observed enrichment of BW association signals across the set of 77 imprinted genes defined by the Genotype-Tissue Expression ; Extended Data Table 2a and  Supplementary Table 14) . Such enrichment is consistent with the 'parental conflict' hypothesis regarding the allocation of maternal resources to the fetus 11 . Although the role of imprinted genes in fetal growth has been described in animal models and rare human disorders 12 , these data provide a large-scale, systematic indication of their contribution to normal variation in BW. Of the 60 genomewide significant loci, two (INS-IGF2 and RB1) fall within (or near) imprinted regions (Extended Data Fig. 2b) , with a noteworthy third signal at DLK1 (previously fetal antigen-1; P = 5.6 × 10 −8 ). Parentof-origin specific analyses to further investigate these individual loci (comparing heterozygote versus homozygote BW variance in 57,715 unrelated individuals, and testing BW associations with paternal versus maternal alleles in 4,908 mother-child pairs; see Methods) proved, despite these sample sizes, to be underpowered (Extended Data Fig. 7 and Supplementary Tables 15, 16) .
Many of the genome-wide signals for BW detected here are also established genome-wide association signals for a wide variety of cardiometabolic traits (Fig. 2) . These include the BW signals near CDKAL1, ADCY5, HHEX-IDE and ANK1 (also genome-wide significant for T2D), NT5C2 (for blood pressure, CAD and BMI) and ADRB1 (for blood pressure). We used two approaches to understand whether this pattern of adult trait association represented a generic property of BW-associated loci or reflected heterogeneous mechanisms linking BW to adult disease.
First, we applied unsupervised hierarchical clustering (Methods) to the non-BW trait association statistics for the 60 significant BW loci. The resultant heat map showed the heterogeneity of locus-specific effect sizes across the range of adult traits ( Fig. 2 and Supplementary Table 17 ). For example, it revealed that the associations between BW-raising alleles and increased adult height are concentrated amongst a subset of loci including HHIP and GNA12, and highlighted particularly strong associations with lipid traits for variants at the TRIB1 and MAFB loci.
Second, we constructed trait-specific 'point-of-contact' (PoC) PPI networks from proteins represented in both the global BW PPI network and equivalent PPI networks generated for each of the adult traits (Methods and Extended Data Figs 6c-e). We reasoned that these PoC PPI networks would be enriched for the specific proteins mediating the observed links between BW and adult traits, generating hypotheses that are amenable to subsequent empirical validation. To highlight processes implicated in specific BW-trait associations, we overlaid these PoC PPI with the top 50 pathways that were over-represented in the global BW PPI network. These analyses revealed, for example, that proteins in the Wnt canonical signalling pathway were detected in the PoC PPI network only for blood pressure traits. We used these PPI overlaps to highlight the specific transcripts within BW GWAS loci that were likely to mediate the mechanistic links. For example, the overlap between the Wnt signalling pathway and the PoC PPI network for the intersection of BW and blood pressure-related traits implicated FZD9 as the likely effector gene at the MLXIPL BW locus (Extended Data Fig. 6d and Supplementary Table 6 ).
We focused our more detailed investigation of the mechanistic links between early growth and adult traits on two phenotypic areas: arterial blood pressure and T2D/glycaemia. Across both the overall GWAS and specifically among the 60 significant BW loci, most BW-raising alleles were associated with reduced blood pressure ( Figs 1, 2) ; the strongest inverse associations were seen for the loci near NT5C2, FES, NRIP1, EBF1 and PTH1R. However, we also observed locus-specific heterogeneity in the genetic relationships between blood pressure and BW: the SBP-raising allele at ADRB1 13 is associated with higher, rather than lower, BW (Extended Data Fig. 8a ). When we considered the reciprocal relationship, that is, the effects on BW of blood-pressure-raising alleles at 30 reported loci for SBP 13, 14 , there was an excess of associations (5 out of 30 with lower BW at P < 0.05; binomial P = 0.0026; Extended Data Fig. 8a ). To dissect maternal and fetal genotype effects at these loci, we tested the impact on BW of a risk score generated from the 30 SBP SNPs, restricted to the untransmitted maternal haplotype score 15 in a set of 5,201 mother-child pairs. Analysis of these loci indicated that maternal genotype effects on the intrauterine environment probably Figure 1 | Genome-wide genetic correlation between BW and a range of traits and diseases in later life. Genetic correlation (R g ) and corresponding s.e. (error bars) between BW and the traits displayed on the x axis were estimated using linkagedisequilibrium score regression (ref. 8) . The genetic correlation estimates (R g ) are colour coded according to their intensity and direction (red for positive and blue for inverse correlation). WHRadjBMI, waist-hip ratio adjusted for body mass index; HOMA-B/IR, homeostasis model assessment of beta-cell function/insulin resistance; HbA1c, haemoglobin A1c; BMD, bone mineral density; ADHD, attention deficit hyperactivity disorder. See Supplementary Table 12 for references for each of the traits and diseases displayed.
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contribute to the inverse genetic correlation between SBP and BW (Methods and Supplementary Table 18), and was consistent with the results of a wider study of > 30,000 women which demonstrated associations between a maternal genetic score for SBP (conditional on fetal genotype) and lower offspring BW 16 . The blood-pressure-raising allele with the largest BW-lowering effect mapped to the NT5C2 locus (index variant for BW, rs74233809, R 2 = 0.98 with index variant for blood pressure, rs11191548; ref. 14) and was also associated with lower adult BMI (R 2 = 0.99 with rs11191560; ref. 17). The BW-lowering allele at rs74233809 is a proxy for a recently described 18 functional variant in the nearby CYP17A1 gene (R 2 = 0.92 with rs138009835). The CYP17A1 gene encodes the cytochrome P450c17α enzyme CYP17 (ref. 19), which catalyses key steps in steroidogenesis that determine the balance between mineralocorticoid, glucocorticoid and androgen synthesis. This variant has been shown to alter transcriptional efficiency in vitro and is associated with increased urinary tetrahydroaldosterone excretion 18 . CYP17A1 is expressed in fetal adrenal glands and testes from early gestation 20 as well as in the placenta 21 . These data suggest that variation in CYP17A1 expression contributes to the observational association between low BW and adult hypertension 22 . When we analysed 45 loci associated with CAD 23 , the inverse genetic correlation between CAD and BW was concentrated amongst the five CAD loci with primary blood pressure associations. This suggests that genetic determinants of blood pressure play a leading role in mediating the life-course associations between BW and CAD (Extended Data Fig. 8b , e).
Linkage-disequilibrium score regression analyses demonstrated overall inverse genetic correlation between lower BW and elevated risk of T2D (Fig. 1) . However, the locus-specific heat map indicates a heterogeneous pattern across individual loci (Fig. 2) . To explore this further, we tested the 84 reported T2D loci 24 for association with BW. Some T2D risk alleles (such as those at ADCY5, CDKAL1 and HHEX-IDE) were strongly associated with lower BW, while others (including ANK1 and MTNR1B) were associated with higher BW (Extended Data Fig. 8c ). This was in contrast with the BW effects of 422 known height loci 25 (Extended Data Fig. 8d ), which showed a strong positive correlation consistent with the overall genetic correlation between height and BW, indicating that the growth effects of many height loci start prenatally and persist into adulthood.
The contrasting associations of T2D-risk alleles with both higher and lower BW probably reflect the differential impacts, across loci, of variation in the maternal and fetal genomes. Observational data link paternal diabetes with lower offspring BW 4 , indicating that the inheritance of T2D risk alleles by the fetus tends, in line with the linkage-disequilibrium score regression analysis, to reduce growth. These relationships are consistent with the precepts of the 'fetal insulin hypothesis' 26 and reflect the potential for reduced insulin secretion and/ or signalling to lead to both reduced fetal growth and, many decades later, enhanced predisposition to T2D. In line with this, the inferred paternal transmitted haplotype score generated from the 84 T2D risk variants was associated with lower BW (P = 0.045) in 5,201 motherchild pairs (Methods and Supplementary Table 18 ). In contrast, maternal diabetes is observationally associated with higher offspring BW 4 , reflecting the ability of maternal hyperglycaemia to stimulate fetal insulin secretion. The contribution of genotype-dependent maternal hyperglycaemia to BW is in line with the evidence, from a recent study, that maternal genotype scores for fasting glucose and T2D (conditional on fetal genotype) were causally associated with higher offspring BW 16 . It is also consistent with the observation that a subset of glucose-raising alleles is associated with higher BW 7 . For example, the T2D-risk variant at MTNR1B (which also has a marked effect on fasting glucose levels in non-diabetic individuals 27,28 ) was amongst the subset of BW loci (5 out of 60) for which the BW effect attributable to maternal genotype exceeded that associated with the fetal genotype (maternal: β = 0.048, P = 5.1 × 10 −15 ; fetal: β = 0.023, P = 2.9 × 10 −8 ) (Supplementary  Table 10 and Extended Data Figs 4, 5) . Thus, both maternal and fetal genetic effects connect BW to later T2D risk, albeit acting in opposing 
directions. When we categorized T2D loci using a classification of physiological functions derived from their effects on related glycaemic and anthropometric traits 27 , we found that T2D-risk alleles associated with lower BW were those typically characterized by reduced insulin processing and secretion without detectable changes in fasting glucose (the 'Beta Cell' cluster in Extended Data Fig. 8f ).
The YTK6 signal at rs138715366 is notable not only because the genetic data indicate that a single low-frequency non-coding variant is driving the association signal (see above) but also because of the proximity of this signal to GCK. Rare coding variants in glucokinase are causal for a form of monogenic hyperglycaemia and lead to large reductions in BW when parental alleles are passed on to their offspring 29 . In addition, common non-coding variants nearby are implicated in T2D risk and fasting hyperglycaemia 28 . However, the latter variants are conditionally independent of rs138715366 (Supplementary Table 19 ) and show no comparable association with lower BW. Either rs138715366 acts through effector transcripts other than GCK, or the impact of the low-frequency SNP near YKT6 on GCK expression involves tissue-and/or temporal-specific variation in regulatory impact.
In conclusion, we have identified 60 genetic loci associated with BW and used them to gain insights into the aetiology of fetal growth and into well-established, but until now poorly understood, life-course disease associations. The evidence that the relationship between early growth and later metabolic disease has an appreciable genetic component contrasts with, but is not necessarily incompatible with, the emphasis on adverse early environmental events highlighted by the fetal origins hypothesis 1 . As we have shown, these genetic effects reflect variation in both the fetal and the maternal genome: the impact of the latter on the offspring's predisposition to adult disease could be mediated, at least in part, through perturbation of the antenatal and early life environment. Future mechanistic and genetic studies should support reconciliation between these alternative, but complementary, explanations for the far-reaching life-course associations that exist between events in early life and predisposition to cardiometabolic disease several decades later. 16 Supplementary Information is available in the online version of the paper.

METHODS
Ethics statement. All human research was approved by the relevant institutional review boards and conducted according to the Declaration of Helsinki. All participants provided written informed consent. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the local Research Ethics Committees. Study-level analyses. No statistical methods were used to predetermine sample size: to maximise power to detect association signals, we set out to collect the largest possible set of samples for which the combination of genome-wide genotyping data and reliable measures of BW could be made available for analysis. Within each study, BW was collected from a variety of sources, including measurements at birth by medical practitioners, obstetric records, medical registers, interviews with the mother and self-report as adults (Supplementary Table 1 ). BW was Z-score transformed separately in males and females. Individuals with extreme BW (> 5 s.d. from the sex-specific study mean), monozygotic or polyzygotic siblings, or preterm births (gestational age < 37 weeks, where this information was available) were excluded from downstream association analyses (Supplementary Table 1) .
Within each study, stringent quality control of the GWAS genotype scaffold was carried out before imputation (Supplementary Table 2) . Each scaffold was then pre-phased and imputed 30, 31 up to reference panels from the 1000G project 2 or the combined 1000G and UK10K projects 3 (Supplementary Table 2 ). Association of BW with each variant passing established GWAS quality control filters 32 was tested in a linear regression framework, under an additive model for the allelic effect, after adjustment for study-specific covariates, including gestational age, where available (Supplementary Table 2 ). Where necessary, population structure was accounted for by adjustment for axes of genetic variation from principal components analysis 33 and subsequent genomic control correction 34 , or inclusion of a genetic relationship matrix in a mixed model 35 (Supplementary Table 2 ). We calculated the genomic control inflation factor (λ) in each study to confirm that study-level population structure was accounted for before meta-analysis. Preparation, quality control and genetic analysis in UK Biobank samples. UK Biobank phenotype data were available for 502,655 participants 36 . All participants in the UK Biobank were asked to recall their BW, of which 279,971 did so at either the baseline or follow-up assessment visit. Of these, 7,686 participants reported being part of multiple births and were excluded from downstream analyses. Ancestry checks, based on self-reported ancestry, resulted in the exclusion of 8,998 additional participants reported not to be white European. Of those individuals reporting BW at baseline and follow-up assessments, 393 were excluded because the two reported values differed by more than 0.5 kg. For those reporting different values (≤ 0.5 kg) between baseline and follow-up, we took the baseline measure forward for downstream analyses. We then excluded 36,716 individuals reporting values < 2.5 kg or > 4.5 kg as implausible for live term births before 1970. In total 226,178 participants had data relating to BW that matched these inclusion criteria.
Genotype data from the May 2015 release were available for a subset of 152,249 participants from UK Biobank. In addition to the quality control metrics performed centrally by UK Biobank, we defined a subset of 'white European' ancestry samples using a K-means (K = 4) clustering approach based on the first four genetically determined principal components. A maximum of 67,786 individuals (40,425 females and 27,361 males) with genotype and valid BW measures were available for downstream analyses. We tested for association with BW, assuming an additive allelic effect, in a linear mixed model implemented in BOLT-LMM (ref. 37 ) to account for cryptic population structure and relatedness. Genotyping array was included as a binary covariate in all models. Total chip heritability (that is, the variance explained by all autosomal polymorphic genotyped SNPs passing quality control) was calculated using restricted maximum likelihood (REML) implemented in BOLT-LMM (ref. 37). We additionally analysed the association between BW and directly genotyped SNPs on the X chromosome: for this analysis, we used 57,715 unrelated individuals with BW available and identified by UK Biobank as white British. We excluded SNPs with evidence of deviation from Hardy-Weinberg equilibrium (P < 1 × 10 −6 ), MAF < 0.01 or overall missing rate > 0.015, resulting in 19,423 SNPs for analysis in Plink v1.07 (http://pngu.mgh.harvard.edu/purcell/ plink/) 38 , with the first five ancestry principal components as covariates. In both the full UK Biobank sample and our refined sample, we observed that BW was associated with sex, year of birth and maternal smoking (P < 0.0015, all in the expected directions), confirming more comprehensive previous validation of self-reported BW 4 . We additionally verified that BW associations with lead SNPs at seven established loci 5 based on self-report in UK Biobank were consistent with those previously published. European ancestry meta-analysis. The European ancestry meta-analysis consisted of two components: (i) 75,891 individuals from 30 GWAS from Europe, USA and Australia; and (ii) 67,786 individuals of white European origin from the UK Biobank. In the first component, we combined sex-specific BW association summary statistics across studies in a fixed-effects meta-analysis, implemented in GWAMA (ref. 39 ) and applied a second round of genomic control 34 (λ GC = 1.001). Subsequently, we combined association summary statistics from this component with the UK Biobank in a European ancestry fixed-effects meta-analysis, implemented in GWAMA (ref. 39) . Variants failing GWAS quality control filters in the UK Biobank, reported in less than 50% of the total sample size in the first component, or with MAF < 0.1%, were excluded from the European ancestry meta-analysis. We aggregated X-chromosome association summary statistics from the UK Biobank (19,423 SNPs) with corresponding statistics from the European GWAS component using fixed effects P-value-based meta-analysis in METAL (ref. 40) (max n = 99,152).
We were concerned that self-reported BW as adults in the UK Biobank would not be comparable with that obtained from more stringent collection methods used in other European ancestry GWAS. In addition, the UK Biobank lacked information on gestational age for adjustment, which could have an impact on strength of association compared with the results obtained from other European ancestry GWAS. However, we observed no evidence of heterogeneity in BW allelic effects at lead SNPs between the two components of European ancestry meta-analysis, using Cochran's Q statistic 41 implemented in GWAMA (ref. 39) after Bonferroni correction (P > 0.00083) (Supplementary Table 3 ). We tested for heterogeneity in allelic effects between studies within the European component using Cochran's Q. At loci demonstrating evidence of heterogeneity, we confirmed that association signals were not driven by outlying studies by visual inspection of forest plots. We performed sensitivity analyses to assess the impact of covariate adjustment (gestational age and population structure) on heterogeneity.
We were also concerned that overlap of individuals (duplicated or related) between the two components of the European ancestry meta-analysis might lead to false positive association signals. We performed bivariate linkage-disequilibrium score regression 8 using the two components of the European ancestry meta-analysis and observed a genetic covariance intercept of 0.0156 ± 0.0058 (s.e.), indicating a maximum of 1,119 duplicate individuals. Univariate linkage-disequilibrium score regression 8 of the European ancestry meta-analysis estimated the intercept as 1.0426, which may indicate population structure or relatedness that was not adequately accounted for in the analysis. To assess the impact of this inflation on the European ancestry meta-analysis, we expanded the standard errors of BW allelic effect size estimates and re-calculated association P values. On the basis of this adjusted analysis, only the lead SNP at MTNR1B dropped below genome-wide significance (rs10830963, P = 5.5 × 10
−8
). Trans-ancestry meta-analysis. The trans-ancestry meta-analysis combined the two European ancestry components with an additional 10,104 individuals from six GWAS from diverse ancestry groups: African American, Chinese, Filipino, Surinamese, Turkish and Moroccan. Within each GWAS, we first combined sex-specific BW association summary statistics in a fixed-effects meta-analysis, implemented in GWAMA (ref. 39 ) and applied a second round of genomic control 34 . Subsequently, we combined association summary statistics from the six non-European GWAS and the two European ancestry components in a transancestry fixed-effects meta-analysis, implemented in GWAMA (ref. 39) . Variants failing GWAS quality control filters in the UK Biobank, reported in less than 50% of the total sample size in the first component, or with MAF < 0.1%, were excluded from the trans-ancestry meta-analysis. We tested for heterogeneity in allelic effects between ancestries using Cochran's Q (ref. 41) . Approximate conditional analysis. We searched for multiple distinct BW association signals in each of the established and novel loci, defined as 1 Mb up-and down-stream of the lead SNP from the trans-ancestry meta-analysis, through approximate conditional analysis. We applied GCTA (ref. 42 ) to identify 'index SNPs' for distinct association signals attaining genome-wide significance (P < 5 × 10 −8
) in the European ancestry meta-analysis using a reference sample of 5,000 individuals of white British origin, randomly selected from the UK Biobank, to approximate patterns of linkage disequilibrium between variants in these regions. Note that we performed approximate conditioning on the basis of only the European ancestry meta-analysis because GCTA cannot accommodate linkage-disequilibrium variation between diverse populations. Prioritizing candidate genes in each BW locus. We combined a number of approaches to prioritize the most likely candidate gene(s) in each BW locus. Expression quantitative trait loci (eQTLs) were obtained from the Genotype Tissue Expression (GTEx) Project 43 , the GEUVADIS project 44 and eleven other studies [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] 59) . Biological candidacy was assessed by presence in significantly enriched gene set pathways from MAGENTA analyses (see below for details). We extracted all genes within 300 kb of all lead BW SNPs and searched for connectivity between any genes using STRING (ref. 60). If two or more genes between two separate BW loci were connected, they were given an increased prior for both being plausible candidates. We also applied protein-protein interaction (PPI) analysis (see below for details) to all genes within 300 kb of each lead BW SNPs and ranked the genes based on the score for connectivity with the surrounding genes. Evaluation of imputation quality of the low-frequency variant at the YKT6-GCK locus. At the YKT6-GCK locus, the lead SNP (rs138715366) was found at a low frequency in European ancestry populations (MAF = 0.92%) and was even rarer in other ancestry groups (MAF = 0.23% in African Americans, otherwise monomorphic) and was not present in the HapMap reference panel 61 . To assess the accuracy of imputation for this low-frequency variant, we genotyped rs138715366 in the Northern Finland Birth Cohort (NFBC) 1966 (Supplementary Table 1) . Of the 5,009 samples in the study, 4,704 were successfully imputed and genotyped (or sequenced) for rs138715366. The overall concordance rate between imputed and directly assayed genotypes was 99.8% and for directly assayed heterozygote calls was 75.0%. Fine-mapping analyses. We investigated linkage-disequilibrium differences between populations contributing to the trans-ancestry meta-analysis and to take advantage of the improved coverage of common and low-frequency variation offered by 1000G or 1000G and UK10K combined imputation to localize variants driving each distinct association signal achieving locus-wide significance. For each distinct signal, we used MANTRA (ref. 62) to construct 99% credible sets of variants 63 that together account for 99% of the posterior probability of driving the association. MANTRA incorporates a prior model of relatedness between studies, based on mean pair-wise allele frequency differences across loci, to account for heterogeneity in allelic effects (Supplementary Table 3 ). MANTRA has been demonstrated, by simulation, to improve localization of causal variants compared with either a fixed-or random-effects trans-ancestry meta-analysis 62, 64 . For loci with only one signal of association, we used MANTRA to combine summary statistics from the six non-European GWAS and the two European ancestry components. However, for loci with multiple distinct association signals, we used MANTRA to combine summary statistics from approximate conditioning for the two European components, separately for each signal.
For each distinct signal, we calculated the posterior probability that the jth variant, π Cj , is driving the association, given by
where the summation is over all variants mapping within the (conditional) meta-analysis across the locus. In this expression, Λ j is the Bayes' factor in favour of association from the MANTRA analysis. A 99% credible set 63 was then constructed by: (i) ranking all variants according to their Bayes' factor, Λ j ; and (ii) including ranked variants until their cumulative posterior probability exceeds 0.99. Genomic annotation. We used genomic annotations of DNaseI hypersensitive sites (DHS) from the ENCODE (ref. 65 project and protein coding genes from GENCODE (ref. 66 ). We filtered cell types that are cancer cell lines (karyotype 'cancer' from https://genome.ucsc.edu/ENCODE/cellTypes.html), and merged data from multiple samples from the same cell type. This resulted in 128 DHS cell-type annotations, as well as 4 gene-based annotations (coding exon, 5′ UTR, 3′ UTR and 1 kb upstream of the transcription start site (TSS)). First, we tested for the effect of each cell type DHS and gene annotation individually using the Bayes' factors for all variants in the 62 credible sets using fgwas (ref. 67 ). Second, we categorized the annotations into 'genic' , 'fetal DHS' , 'embryonic DHS' , 'stem cell DHS' , 'neonatal DHS' and 'adult DHS' based on the description fields from ENCODE, and tested for the effect of each category individually as described above using fgwas. Third, we then tested the effect of each category by including all categories in a joint model using fgwas. For each of the three analyses, we obtained the estimated effects and 95% confidence intervals (CI) for each annotation, and considered an annotation enriched if the 95% CI did not overlap zero. Estimation of genetic variance explained. The 'variance explained' statistic was calculated using the REML method implemented in GCTA (ref. 68) . We considered the variance explained by two sets of SNPs: (i) lead SNPs of all 62 distinct association signals at the 59 established and novel autosomal BW loci identified in the European-specific or trans-ancestry meta-analyses; (ii) lead SNPs of 55 distinct association signals at the 52 novel autosomal BW loci (Extended Data Table 1a and Supplementary Table 7 ). The 'variance explained' was calculated in samples of European ancestry in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study 69 (independent of the meta-analysis) and two studies that were part of the European ancestry meta-analysis: NFBC1966 and Generation R (Supplementary Table 1) . In each study, the genetic relationship matrix was estimated for each set of SNPs and was tested individually against BW (males and females combined) with study specific covariates. These analyses provided an estimate and s.e. for the variance explained by each of the given sets of SNPs. Examining the relative effects on BW of maternal and fetal genotype at the 60 identified loci. We performed four sets of analyses. First, we used GWAS data from 4,382 mother-child pairs in the Avon Longitudinal Study of Parents and Children (ALSPAC) study to fit a 'maternal-GCTA model' 6 to estimate the extent to which the maternal genome might influence offspring BW independent of the fetal genome. The maternal-GCTA model uses genome-wide genetic similarity between mothers and offspring to partition the phenotypic variance in BW into components due to the maternal genotype, the child's genotype, the covariance between the two and environmental sources of variation.
Second, we compared associations with BW of the fetal versus maternal genotype at each of the 60 BW loci. The maternal allelic effect on offspring BW was obtained from a maternal GWAS meta-analysis of 68,254 European mothers from the EGG Consortium (n = 19,626) 7 and the UK Biobank (n = 48,628). In the UK Biobank, mothers were asked to report the BW of their first child. Women of European ancestry with genotype data available in the May 2015 data release were included, and those with reported BW equivalent to < 2.5 kg or > 4.5 kg were excluded. No information on gestational age or gender of child was available. BW of first child was associated with maternal factors such as smoking status, BMI and height in the expected directions. Of the 68,254 women included in the maternal GWAS, 13% were mothers of individuals included in the current fetal European ancestry GWAS, and a further ~45% were themselves (with their own BW) included in the fetal GWAS.
Third, we additionally conducted analyses in 12,909 mother-child pairs from nine contributing studies: at each of the 60 loci, we compared the effect of the fetal genotype on BW adjusted for sex and gestational age, with and without adjustment for maternal genotype. We reciprocally compared the association between the maternal genotype and BW with and without adjustment for fetal genotype.
Fourth, we used the method of Zhang et al. 15 to test associations between BW and the maternal untransmitted, maternal transmitted and inferred paternal transmitted haplotype score of 422 height SNPs 25 , 30 SBP SNPs 13, 14 and 84 T2D SNPs 24 in 5,201 mother-child pairs from the ALSPAC study. Linkage-disequilibrium score regression. The use of linkage-disequilibrium score regression to estimate the genetic correlation between two traits/diseases has been described in detail elsewhere 70 . Briefly, the linkage-disequilibrium score is a measure of how much genetic variation each variant tags; if a variant has a high linkage-disequilibrium score then it is in high linkage disequilibrium with many nearby polymorphisms. Variants with high linkage-disequilibrium scores are more likely to contain more true signals and hence provide more chance of overlap with genuine signals between GWAS. The linkage-disequilibrium score regression method uses summary statistics from the GWAS meta-analysis of BW and the other traits of interest, calculates the cross-product of test statistics at each SNP, and then regresses the cross-product on the linkage-disequilibrium score. Bulik-Sullivan et al. 70 show that the slope of the regression is a function of the genetic covariance between traits:
where N i is the sample size for study i, ρ g is the genetic covariance, M is the number of SNPs in the reference panel with MAF between 5% and 50%, l j is the linkagedisequilibrium score for SNP j, N s quantifies the number of individuals that overlap both studies, and ρ is the phenotypic correlation amongst the N s overlapping samples. Thus, if there is sample overlap (or cryptic relatedness between samples), it will only affect the intercept from the regression (that is, the term ) and not the slope, and hence estimates of the genetic covariance will not be biased by sample overlap. Likewise, population stratification will affect the intercept but will have minimal impact on the slope (that is, intuitively since population stratification does not correlate with linkage disequilibrium between nearby markers).
Summary statistics from the GWAS meta-analysis for traits and diseases of interest were downloaded from the relevant consortium website. The summary statistics files were reformatted for linkage-disequilibrium score regression analysis using the munge_sumstats.py python script provided on the developer's website (https://github.com/bulik/ldsc). For each trait, we filtered the summary statistics to the subset of HapMap 3 SNPs 71 , as advised by the developers, to ensure that no bias was introduced due to poor imputation quality. Summary statistics from the European-specific BW meta-analysis were used because of the variable linkage-disequilibrium structure between ancestry groups. Where the sample size for each SNP was included in the results file this was flagged using N-col; if no sample size was available then the maximum sample size reported in the reference for the GWAS meta-analysis was used. SNPs were excluded for the LETTER RESEARCH following reasons: MAF < 0.01; ambiguous strand; duplicate rsID; non-autosomal SNPs; reported sample size less than 60% of the total available. Once all files were reformatted, we used the ldsc.py python script, also on the developers' website, to calculate the genetic correlation between BW and each of the traits and diseases. The European linkage-disequilibrium score files calculated from the 1000G reference panel and provided by the developers were used for the analysis. Where multiple GWAS meta-analyses had been conducted on the same phenotype (that is, over a period of years), the genetic correlation with BW was estimated using each set of summary statistics and presented in Supplementary Table 12 . The phenotypes with multiple GWAS included height, BMI, waist-hip ratio (adjusted for BMI), total cholesterol, triglycerides, high density lipoprotein (HDL) and low density lipoprotein (LDL). The estimate of the genetic correlation between the multiple GWAS meta-analyses on the same phenotype were comparable and the later GWAS had a smaller standard error due to the increased sample size, so only the genetic correlation between BW and the most recent meta-analyses were presented in Fig. 2 .
In the published GWAS for blood pressure 14 the phenotype was adjusted for BMI. Caution is needed when interpreting the genetic correlation between BW and BMI-adjusted SBP owing to the potential for collider bias 72 . Since BMI is associated with both blood pressure and BW, it is possible that the use of a blood pressure genetic score adjusted for BMI might bias the genetic correlation estimate towards a more negative value. To verify that the inverse genetic correlation with BW (r g = − 0.26, s.e. = 0.05, P = 6.5 × 10 ) was not due to collider bias caused by the BMI adjustment of the phenotype, we obtained an alternative estimate using UK Biobank GWAS data for SBP that was unadjusted for BMI and obtained a similar result (R g = − 0.22, s.e. = 0.03, P = 5.5 × 10
−13
). The SBP phenotype in the UK Biobank was prepared as follows. Two blood pressure readings were taken at assessment, approximately 5 min apart. We included all individuals with an automated blood pressure reading (taken using an automated Omron blood pressure monitor). Two valid measurements were available for most participants (averaged to create a blood pressure variable, or alternatively a single reading was used if only one was available). Individuals were excluded if the two readings differed by more than 4.56 s.d. Blood pressure measurements more than 4.56 s.d. away from the mean were excluded. We accounted for blood pressure medication use by adding 15 mm Hg to the SBP measure. Blood pressure was adjusted for age, sex and centre location and then inverse rank normalized. We performed the GWAS on 127,698 individuals of British descent using BOLT-LMM (ref. 37) , with genotyping array as covariate. Estimating the proportion of the BW-adult traits covariance attributable to genotyped SNPs. We estimated the phenotypic, genetic and residual correlations as well as the genetic and residual covariance between BW and several quantitative traits and/or disease outcomes in the UK Biobank using directly genotyped SNPs and the REML method implemented in BOLT-LMM (ref. 37) . The traits examined included T2D, SBP, diastolic blood pressure, CAD, height, BMI, weight, waist-hip ratio, hip circumference, waist circumference, obesity, overweight, age at menarche, asthma, and smoking. Where phenotypes were not available (for example, serum blood measures are not currently available in the UK Biobank), we obtained estimates using the NFBC1966 study (for correlations/covariance between BW and triglycerides, total cholesterol, HDL, LDL, fasting glucose and fasting insulin). In the UK Biobank analysis, we used 57,715 unrelated individuals with BW available and identified by the UK Biobank as white British. SNPs with evidence of deviation from Hardy-Weinberg equilibrium (P < 1 × 10 −6 ), MAF < 0.05 or overall missing rate > 0.015 were excluded, resulting in 328,928 SNPs for analysis. We included the first five ancestry principal components as covariates. In the NFBC1966 analysis, 5,009 individuals with BW were enrolled. Genotyped SNPs that passed quality control (Supplementary Table 2 ) were included, resulting in 324,895 SNPs for analysis. The first three ancestry principal components and sex were included as covariates. Gene set enrichment analysis. Meta-analysis gene-set enrichment of variant associations (MAGENTA) was used to explore pathway-based associations using summary statistics from the trans-ancestry meta-analysis. MAGENTA implements a gene set enrichment analysis (GSEA) based approach, as previously described 9 . Briefly, each gene in the genome was mapped to a single index SNP with the lowest P value within a 110 kb upstream and 40 kb downstream window. This P value, representing a gene score, was then corrected for confounding factors such as gene size, SNP density and linkage-disequilibrium-related properties in a regression model. Genes within the HLA-region were excluded from analysis due to difficulties in accounting for gene density and linkage-disequilibrium patterns. Each mapped gene in the genome was then ranked by its adjusted gene score. At a given significance threshold (95th and 75th percentiles of all gene scores), the observed number of gene scores in a given pathway, with a ranked score above the specified threshold percentile, was calculated. This observed statistic was then compared to 1,000,000 randomly permuted pathways of identical size. This generates an empirical GSEA P value for each pathway. Significance was attained when an individual pathway reached a FDR < 0.05 in either analysis. In total, 3,216 pre-defined biological pathways from Gene Ontology, PANTHER, KEGG and Ingenuity were tested for enrichment of multiple modest associations with BW. The MAGENTA software was also used for enrichment testing of custom gene sets. Protein-protein interaction network analyses. We used the integrative protein-interaction-network-based pathway analysis (iPINBPA) method 73 . Briefly, we generated gene-wise P values from the trans-ancestry meta-analysis using VEGAS2 (ref. 74) , which mapped the SNPs to genes and accounted for possible confounders, such as linkage-disequilibrium between markers. The empirical gene-wise P values were calculated using simulations from the multivariate normal distribution. Those that were nominally significant (P ≤ 0.01) were selected as 'seed genes' , and were collated within a high confidence version of inweb3 (ref. 75 ) to weight the nodes in the network following a guilt-by-association approach. In a second step, a network score was defined by the combination of the Z scores derived from the gene-wise P values with node weights using the Liptak-Stouffer method 76 . A heuristic algorithm was then applied to extensively search for modules enriched in genes with low P values. The modules were further normalized using a null distribution of 10,000 random networks. Only those modules with Z score > 5 were selected. Finally, the union of all modules constructed a BW-overall PPI network. Both the proteins on the individual modules and on the overall BW-PPI were interrogated for enrichment in Gene Ontology terms (biological processes) using a hypergeometric test. Terms were considered as significant when the adjusted P value, following the BenjaminiHochberg procedure, was below 0.05. Point of contact analyses. The same methodology described above was applied to 16 different adult traits resulting in a number of enriched modules per trait. Different modules for each trait were combined in a single component and the intersection between these trait-specific components and the BW component was calculated. This intersection was defined as the PoC network. We used the resulting PoC networks in downstream analyses to interrogate which set of proteins connected BW variation and adult trait variation via pathways enriched in the overall BW analysis. Parent-of-origin specific associations. We first searched for evidence of parent-of-origin effects in the UK Biobank samples by comparing variance between heterozygotes and homozygotes using Quicktest (ref. 77) . In this analysis, we used only unrelated individuals identified genetically as of white British origin (n = 57,715). Principal components were generated using these individuals and the first five were used to adjust for population structure as covariates in the analysis, in addition to a binary indicator for genotyping array.
We also examined 4,908 mother-child pairs in ALSPAC and determined the parental origin of the alleles where possible 78 . Briefly, the method used motherchild pairs to determine the parent of origin of each allele. For example, if the mother/child genotypes were AA/Aa, the child's maternal/paternal allele combination was A/a. For the situation where both mother and child were heterozygous, the child's maternal/paternal alleles could not be directly specified. However, the parental origin of the alleles could be determined by phasing the genotype data and comparing maternal and child haplotypes. We then tested these alleles for association with BW adjusting for sex and gestational age.
Statistical power in these currently available sample sizes was insufficient to rule out widespread parent-of-origin effects across the regions tested. Using the mean β (0.034 s.d.) and MAF (0.28) of the identified loci, we estimate that we would need at least 200,000 unrelated individuals or 70,000 mother-child pairs for 80% power to detect parent-of-origin effects at P < 0.00085. Hierarchical clustering of BW loci. To explore the different patterns of association between BW and other anthropometric/metabolic/endocrine traits and diseases, we performed hierarchical clustering analysis. The lead SNP (or proxy, EUR R 2 > 0.6) at the 60 BW loci was queried in publicly available GWAS metaanalysis datasets or in GWAS results obtained through collaboration 79 . Results were available for 53 of those loci and the extracted Z score (allelic effect/s.e., Supplementary Table 17) was aligned to the BW-raising allele. We performed two dimensional clustering by trait and by locus. We computed the Euclidean distance amongst Z scores of the extracted traits and loci and performed complete hierarchical clustering implemented in the pvclust package (http://www.sigmath. es.osaka-u.ac.jp/shimo-lab/prog/pvclust/) in R v3.2.0 (http://www.R-project.org/). Clustering uncertainty was measured by multiscale bootstrap resampling estimated from 1,000 replicates. We used α = 0.05 to define distinct clusters and, based on the bootstrap analysis, calculated the Calinski index to identify the number of well-supported clusters (cascadeKM function, vegan package, http://CRAN.Rproject.org/package= vegan). Clustering was visualized by constructing dendrograms and a heat map. (main panel) and QQ (top right) plots of trans-ethnic GWAS metaanalysis for BW highlighting the reported imprinted regions described in Supplementary Table 14 . Novel association signals that reached genomewide significance (P < 5 × 10 −8 ) and mapped to imprinted regions are shown in green. Genomic regions outside imprinted regions are shaded in grey. SNPs in the imprinted regions are shown in light blue or dark blue, depending on chromosome number (odd or even). In the QQ plot, the black dots represent observed P values and the grey lines represent expected P values and their 95% confidence intervals under the null distribution for the SNPs within the imprinted regions.
